As we approach our topline data from the ongoing Phase 2b clinical trial of KPI-012 in the second quarter of 2025, it is the right time to transition leadership to Todd, who I have had the privilege ...
As we approach our topline data from the ongoing Phase 2b clinical trial of KPI-012 in the second quarter of 2025, it is the right time to transition leadership to Todd, who I have had the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback